Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Accumulated Expenses (2017 - 2022)

Greater Cannabis Company's Accumulated Expenses history spans 6 years, with the latest figure at $233000.0 for Q1 2022.

  • For Q1 2022, Accumulated Expenses rose 28524.08% year-over-year to $233000.0; the TTM value through Mar 2022 reached $233000.0, up 28524.08%, while the annual FY2021 figure was $18199.0, 8.01% up from the prior year.
  • Accumulated Expenses reached $233000.0 in Q1 2022 per GCAN's latest filing, up from $18199.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $233000.0 in Q1 2022 to a low of $814.0 in Q1 2021.
  • Average Accumulated Expenses over 5 years is $34490.1, with a median of $15361.0 recorded in 2018.
  • Peak YoY movement for Accumulated Expenses: tumbled 93.1% in 2021, then soared 28524.08% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $85000.0 in 2018, then tumbled by 41.18% to $50000.0 in 2019, then plummeted by 66.3% to $16849.0 in 2020, then increased by 8.01% to $18199.0 in 2021, then surged by 1180.29% to $233000.0 in 2022.
  • Per Business Quant, the three most recent readings for GCAN's Accumulated Expenses are $233000.0 (Q1 2022), $18199.0 (Q4 2021), and $12308.0 (Q3 2021).